190 related articles for article (PubMed ID: 29981733)
1. [Venous thromboembolism and pancreatic cancer].
Frère C; Bournet B; Benzidia I; Jamelot M; Debourdeau P; Hij A; Rafii-Elayoubi H; Buscail L; Farge D;
J Med Vasc; 2018 Jul; 43(4):246-254. PubMed ID: 29981733
[TBL] [Abstract][Full Text] [Related]
2. Benefit and risk of primary thromboprophylaxis in ambulatory patients with advanced pancreatic cancer receiving chemotherapy: a systematic review and meta-analysis of randomized controlled trials.
Tun NM; Guevara E; Oo TH
Blood Coagul Fibrinolysis; 2016 Apr; 27(3):270-4. PubMed ID: 26963028
[TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
[TBL] [Abstract][Full Text] [Related]
4. Burden of venous thromboembolism in patients with pancreatic cancer.
Frere C
World J Gastroenterol; 2021 May; 27(19):2325-2340. PubMed ID: 34040325
[TBL] [Abstract][Full Text] [Related]
5. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
[TBL] [Abstract][Full Text] [Related]
6. Compliance with recommendations of clinical practice in the management of venous thromboembolism in cancer: the CARMEN study.
Sevestre MA; Belizna C; Durant C; Bosson JL; Vedrine L; Cajfinger F; Debourdeau P; Farge D;
J Mal Vasc; 2014 May; 39(3):161-8. PubMed ID: 24746736
[TBL] [Abstract][Full Text] [Related]
7. Low molecular weight heparin (LMWH) for primary thrombo-prophylaxis in patients with solid malignancies - systematic review and meta-analysis.
Ben-Aharon I; Stemmer SM; Leibovici L; Shpilberg O; Sulkes A; Gafter-Gvili A
Acta Oncol; 2014 Sep; 53(9):1230-7. PubMed ID: 25162954
[TBL] [Abstract][Full Text] [Related]
8. Venous thromboembolism in cancer patients undergoing major surgery.
Osborne NH; Wakefield TW; Henke PK
Ann Surg Oncol; 2008 Dec; 15(12):3567-78. PubMed ID: 18841419
[TBL] [Abstract][Full Text] [Related]
9. The impact of thromboprophylaxis with LMWHs on the survival of patients with pancreatic cancer.
Sarantis P; Karamouzis MV
Thromb Res; 2022 May; 213 Suppl 1():S120-S126. PubMed ID: 36210553
[TBL] [Abstract][Full Text] [Related]
10. Preventing venous thromboembolism in hospitalized patients with cancer: improving compliance with clinical practice guidelines.
Brown A
Am J Health Syst Pharm; 2012 Mar; 69(6):469-81. PubMed ID: 22382477
[TBL] [Abstract][Full Text] [Related]
11. Prevention and Treatment of Venous Thromboembolism in Patients with Cancer: Focus on Drug Therapy.
van Es N; Bleker SM; Wilts IT; Porreca E; Di Nisio M
Drugs; 2016 Mar; 76(3):331-41. PubMed ID: 26729187
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism in metastatic pancreatic cancer.
Laderman L; Sreekrishnanilayam K; Pandey RK; Handorf E; Blumenreich A; Sorice KA; Lynch SM; Cheema K; Nagappan L; Sosa IR; Dotan E; Vijayvergia N
Eur J Haematol; 2023 Jun; 110(6):706-714. PubMed ID: 36941225
[TBL] [Abstract][Full Text] [Related]
13. [Cancer and venous thromboembolism recurrence: The keys for an optimal management].
Mahé I; Benhamou Y; Helfer H; Chidiac J
Bull Cancer; 2018 May; 105(5):508-516. PubMed ID: 29544692
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis on anticoagulation and prevention of thrombosis and mortality among patients with lung cancer.
Fuentes HE; Oramas DM; Paz LH; Casanegra AI; Mansfield AS; Tafur AJ
Thromb Res; 2017 Jun; 154():28-34. PubMed ID: 28402864
[TBL] [Abstract][Full Text] [Related]
15. [Low molecular weight heparin as venous thromboembolism prophylaxis in hospitalized medical patients].
Sabroe JE; Madsen SM
Ugeskr Laeger; 2016 Jun; 178(25):. PubMed ID: 27401989
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of US prescription patterns: Are treatment guidelines for cancer-associated venous thromboembolism being followed?
Khorana AA; Yannicelli D; McCrae KR; Milentijevic D; Crivera C; Nelson WW; Schein JR
Thromb Res; 2016 Sep; 145():51-3. PubMed ID: 27485998
[TBL] [Abstract][Full Text] [Related]
17. The incidence and risk factors of recurrent venous thromboembolism during pregnancy.
Galambosi PJ; Ulander VM; Kaaja RJ
Thromb Res; 2014 Aug; 134(2):240-5. PubMed ID: 24835671
[TBL] [Abstract][Full Text] [Related]
18. [New international guidelines for curative treatment and prophylaxis for venous thromboembolism (VTE) in cancer patients and the dedicated smartphone application].
Benzidia I; Connault J; Solanilla A; Michon-Pasturel U; Jamelot M; Nguessan MK; Hij A; Le Maignan C; Farge D; Frère C;
J Med Vasc; 2017 Dec; 42(6):375-383. PubMed ID: 29203044
[TBL] [Abstract][Full Text] [Related]
19. Vitamin K Antagonists Compared to Low-Molecular-Weight Heparins for Treatment of Cancer-Associated Venous Thromboembolism: An Observational Study in Routine Clinical Practice. An Observational Study in Routine Clinical Practice.
den Exter PL; Hooijer J; van der Hulle T; van Oosten JP; Dekkers OM; Klok FA; Huisman MV
Thromb Haemost; 2017 Nov; 117(11):2163-2167. PubMed ID: 28981552
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism in patients with advanced cancer under palliative care: additional risk factors, primary/secondary prophylaxis and complications observed under normal clinical practice.
Soto-Cárdenas MJ; Pelayo-García G; Rodríguez-Camacho A; Segura-Fernández E; Mogollo-Galván A; Giron-Gonzalez JA
Palliat Med; 2008 Dec; 22(8):965-8. PubMed ID: 18952751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
